SEC Form D filing
Imbria Pharmaceuticals, Inc., 2025-04-01
An SEC Form D private-offering notice from Boston, MA, a $144,195,814 filer-stated offering target in Biotech. Filed 2025-04-01. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Imbria Pharmaceuticals, Inc. Verified via SEC Form D
Filed 2025-04-01Filed to raise $144,195,814First money in 2025-03-10Raised so far $66,695,817HQ (as filed) Boston, MASector Biotech machine-classified from the filing aloneStage (inferred) LateCall status Delayed filing
Source linked the Form D on EDGAR↗Named in the filing 8 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
The Monday funding list, free
The ones worth a call first, then every company that filed last week, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.